- Home
- BNTX vs EL Comparison
BNTX vs EL Comparison
Compare BNTX & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- EL
- Stock Information
- Founded
- BNTX 2008
- EL 1946
- Country
- BNTX Germany
- EL United States
- Employees
- BNTX N/A
- EL N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- EL Package Goods/Cosmetics
- Sector
- BNTX Health Care
- EL Consumer Discretionary
- Exchange
- BNTX Nasdaq
- EL Nasdaq
- Market Cap
- BNTX 26.4B
- EL 33.0B
- IPO Year
- BNTX 2019
- EL 1995
- Fundamental
- Price
- BNTX $98.15
- EL $88.20
- Analyst Decision
- BNTX Strong Buy
- EL Buy
- Analyst Count
- BNTX 18
- EL 20
- Target Price
- BNTX $139.49
- EL $88.20
- AVG Volume (30 Days)
- BNTX 1.2M
- EL 3.7M
- Earning Date
- BNTX 11-03-2025
- EL 10-30-2025
- Dividend Yield
- BNTX N/A
- EL 1.58%
- EPS Growth
- BNTX N/A
- EL N/A
- EPS
- BNTX N/A
- EL N/A
- Revenue
- BNTX $3,380,387,551.00
- EL $14,326,000,000.00
- Revenue This Year
- BNTX N/A
- EL $6.13
- Revenue Next Year
- BNTX $13.50
- EL $4.22
- P/E Ratio
- BNTX N/A
- EL N/A
- Revenue Growth
- BNTX 6.98
- EL N/A
- 52 Week Low
- BNTX $81.20
- EL $48.37
- 52 Week High
- BNTX $131.49
- EL $103.44
- Technical
- Relative Strength Index (RSI)
- BNTX 40.46
- EL 48.91
- Support Level
- BNTX $90.12
- EL $83.45
- Resistance Level
- BNTX $100.84
- EL $88.42
- Average True Range (ATR)
- BNTX 3.99
- EL 2.42
- MACD
- BNTX -0.47
- EL -0.31
- Stochastic Oscillator
- BNTX 32.42
- EL 46.12
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About EL Estee Lauder Companies Inc. (The)
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%), with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.